返回 Agenda
Session Chair(s)
Isabelle Stoeckert, PHARMD, PMP
Independent Regulatory Science Expert
Independent, Germany
Speaker(s)
New Tasks for CMDh – How do the new pharmacovigilance processes work?
Peter Bachmann
Federal Institute for Drugs and Medical Devices (BfArM), Germany
Retired from Head International Liaison Office and Conferences, Executive Depart
Sharing Perspectives in a Complex Environment – CHMP´s first experiences with the new pharmacovigilance processes
Tomas Salmonson, DrMed, PHD
Critical Path Institute, Netherlands
First Experiences with the New Pharmacovigilance Processes in Close Interaction with CHMP and CMDh – the PRAC perspective
George Aislaitner
National Drugs Organization of Greece, Greece